# Intermax Pharmaceuticals,  Inc. – FDA Inspection, Feb 3, 2009

Source: https://www.keypedia.com/records/fda_inspections/intermax-pharmaceuticals-inc/2623c505-7353-42a9-8fa3-489cbcce9049
Source feed: FDA_Inspections

> FDA inspection 560581 of Intermax Pharmaceuticals,  Inc., February 03, 2009. Classification: Official Action Indicated (OAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 560581
- Company Name: Intermax Pharmaceuticals,  Inc.
- Inspection Date: 2009-02-03
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 768948 - 2012-02-21](https://www.keypedia.com/records/fda_inspections/intermax-pharmaceuticals-inc/960e9723-af65-444f-8cb1-e924706dc32b)
- [FDA Inspection 754912 - 2011-11-28](https://www.keypedia.com/records/fda_inspections/intermax-pharmaceuticals-inc/13ec96e5-3c35-4bc2-81df-0f8fae43900d)
- FDA Inspection 696893 - 2010-11-08
- FDA Inspection 659964 - 2010-04-28

Company: https://www.keypedia.com/companies/intermax-pharmaceuticals-inc/5fa66a1e-9f62-4212-8374-afbf263836eb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c